The Good, the Bad, and the Ugly: Cramer’s Take on BlackRock, SolarEdge, and Axsome Therapeutics
BlackRock, Inc.’s Stellar Performance Reflecting on the recent market actions, Jim Cramer couldn’t help but commend BlackRock, Inc.’s sensational quarterly performance. He urged investors to consider investing in the company, emphasizing the magnitude of the achievement. Due to the postponement of the SEC’s decision on BlackRock’s proposed Ethereum exchange-traded fund, investors will have to wait ...











